Trending News
News
News
Horizon Pharma, Vidara Therapeutics International Ltd Acquisition to Become Horizon Pharma plc
The acquisition accelerates Horizon's transformation to a profitable specialty pharma company.
News
BioLineRx Completes Dose Escalation Stage of Phase 1/2 Study for Novel Celiac Treatment
Single administration of BL-7010 was safe and well tolerated at all doses tested.
News
Trophos Announces Top-Line Results in Pivotal Trial of Olesoxime in SMA
Promising results for the maintenance of motor function in spinal muscular atrophy - a rare, serious and debilitating pediatric-onset neurodegenerative disease.
News
MarcoPolo Pharmaceuticals Announces a Positive Phase II-III Study in Partial Seizure Patients
Double-blind, placebo-controlled clinical study to evaluate the efficacy, safety and tolerability of VLB-01.
News
Sepsis Study Comparing Three Treatment Methods Shows Same Survival Rate
NIH-funded clinical trial tested specific protocols against usual high-level care.
News
Pioneering Human Protein Atlas Project Achieves a Major Milestone
Project leverages Luminex's xMAP® technology for biobank profiling research.
News
Natera Announces Launch of Panorama™ NIPT in Portugal and Thailand
Company announces two new partnerships to launch Panorama™ outside of the US.
News
MIT Chemists Devise Novel Way to Manufacture Peptide Drugs
New, fast synthetic method enables manufacture of peptides in hours, which could boost drug development.
News
UCL’s Novel Approach to Research in Biologically-Relevant Models
Cellectricon and UCL unite to present a webinar, March 27, 11am-12pm EDT.
News
CiToxLAB Appoints John C. Kapeghian as Senior Director of Toxicology
This appointment makes the Montreal site attractive to North American clients and boosts CiToxLAB’s expertise in preclinical development and regulatory affairs.
Advertisement